At a glance: Studies of zinc and the common cold mainly concern defined preparations, often lozenges. They do not establish colloidal zinc as a proven remedy for a cold or influenza.
What the 2024 review found
A Cochrane review found that zinc treatment might shorten an existing cold, but confidence in this finding was low. For prevention, the evidence suggested little or no difference. The studies varied considerably in their preparations, methods and reported outcomes.
This is a qualified result about the products studied, not evidence that every zinc product prevents infection or speeds recovery.
Which forms were studied?
Many trials used zinc acetate or zinc gluconate lozenges. Other formulations and routes also appeared. The differences complicate comparisons even within the research.
A colloidal dispersion is not automatically chemically or pharmacologically equivalent to a lozenge. Calling both zinc does not establish comparable exposure or effects.
Why PPM is not a clinical dose
A concentration figure needs a defined basis and the amount used before it can describe an exposure. It also does not identify the zinc compound, dissolved fraction or behaviour of the finished preparation.
Contact time, route and total intake matter. A study dose cannot be transferred to an unspecified dispersion simply by matching a number on a bottle.
Side effects and route-specific concerns
Non-serious adverse effects, including taste disturbance and digestive discomfort, were more frequent in the treatment studies. These matter when considering an uncertain benefit.
Zinc used inside the nose raises separate concerns; some intranasal products have been associated with loss of smell. Do not turn an oral or technical zinc liquid into a nasal preparation. Prolonged excessive zinc intake can also interfere with copper status, and interactions with medicines need attention.
A cold or a different illness?
Symptoms can overlap with influenza, COVID-19, allergies and other conditions. A study about the common cold does not establish treatment for all illnesses with cough or a runny nose.
Breathing difficulty, chest pain, marked deterioration or persistent high fever need medical assessment. People at higher risk should seek advice appropriate to their circumstances rather than rely on an unproven product.
How to read a zinc claim
Ask which formulation was tested, by which route, for prevention or treatment, and with what uncertainty and side effects. The evidence for a defined zinc preparation cannot be used as a blanket endorsement of colloidal zinc.
This guide does not give a supplement regimen. Selection and interactions should be considered for the actual product and person.
Frequently asked questions
Do zinc-lozenge results also apply to colloidal zinc?
Not automatically. The compound, formulation, route and amount differ and need to match the studied preparation.
Do cold studies also prove a benefit against influenza?
No. A common cold and influenza are different illnesses. A result concerning cold duration does not establish efficacy for influenza or other infections.
Related guides
- Colloidal zinc for skin, hair and nails: nutrition versus treatment claims
- What is colloidal zinc? Nutrient facts and product differences
Sources and further reading
- Cochrane (2024): Zinc for prevention and treatment of the common cold
- NIH Office of Dietary Supplements: Zinc
- EUR-Lex: Regulation 432/2012 on authorised health claims
Editorial update: 4 October 2026. General information; not an individual diagnosis, treatment, ingestion or dosage recommendation.